PPARA and metabolic dysfunction-associated steatotic liver disease: Fenofibrate upregulated PPARα and the mitochondrial biosynthesis related molecule PGC-1α, reduced oxidative stress damage and accumulation of lipids within the hepatocytes, and slowed down NAFLD pathology.